SCHEMBL5126372

SCHEMBL5126372

COC(=O)C1CCCc2cc(OC)ccc2N1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MTNR1B P49286 3/20 0.42
MTNR1A P48039 3/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
IGF1R P08069 1/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
ACHE P22303 2/20 0.40
NQO2 P16083 1/20 0.40
ATM Q13315 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7335768 0.92 ALDH1A1 (0.51) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL30358032 0.92 ALDH1A1 (0.51) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL3817730 0.88 HSD17B10 (0.59) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL7286562 0.83 ALDH1A1 (0.44) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL1760643 0.83 ALDH1A1 (0.44) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL5567814 0.83 ALDH1A1 (0.44) HSD17B10ALDH1A1TP53CYP1A2HPGD
Hydrochloric Acid SCHEMBL11048761 0.78 HSD17B10 (0.64) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL28634734 0.76 MTNR1A (0.44) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL4999513 0.76 MTNR1A (0.44) HSD17B10ALDH1A1TP53CYP1A2HPGD
SCHEMBL3893061 0.76 IGF1R (0.46) HSD17B10ALDH1A1TP53CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188460-A1 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188460-A1 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them BAX, BCL2, CASP3 HSD17B10 426/4885ALDH1A1 2299/4885TP53 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.